Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

RITE AID CORPORATION (RAD)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Rite Aid February Same-Store Sales Rose 3.1%; Up 3% In 4Q

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2012 | 03:07pm CET

Rite Aid Corp.'s (>> Rite Aid Corporation) same-store sales rose 3.1% in February, marking the 11th straight month of growth for the drug store chain.

The No. 3 U.S. drug store chain behind Walgreen Co. (>> Walgreen Company) and CVS Caremark Corp. (>> CVS Caremark Corporation) reported same-store sales growth in all but one month last year -- March had a 0.1% drop -- with a boost from the rollout of a loyalty program and store renovations that expanded clinical pharmacy services and health and wellness products choices.

During February, same-store sales were up 1.9% in the front of the store. Pharmacy same-store sales increased 3.7%, despite a negative impact of 2.42 percentage points from generic drug introductions. Same-store prescription counts were up 2.2%.

For the fiscal fourth quarter ended March 3, same-store sales improved 3%, including growth of 1.6% in the front of the store and 3.8% in the pharmacy section.

Total February drug store sales rose 2.3% to $2.55 billion. Prescription sales accounted for 68.3% of drugstore sales.

For the quarter, total drug store sales rose 2.5% to $7.12 billion.

Rite-Aid, which has about 4,667 stores, has posted losses since its 2007 acquisition of the Brooks Eckerd Pharmacy chain stores that saddled it with debt just before consumers slashed spending.

The company in December reported that its fiscal third-quarter loss narrowed as same-store sales grew for a fourth consecutive quarter and interest expense and lease termination and write-down charges declined.

Shares were up 1.2% at $1.71 in recent premarket trading. Through Wednesday's close, the stock is up by slightly more than a third this year.

 
   -By Tess Stynes, Dow Jones Newswires; 212-416-2481; [email protected] 
 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
11/21 RITE AID : Foundation Unveils KIDCHAMPSM Program
11/21 RITE AID : Lowest Offers of the Year Return Black Friday
11/20 RITE AID CORPORATION (NYSE : RAD) Files An 8-K Departure of Directors or Certain..
11/17 RITE AID CORP : Change in Directors or Principal Officers, Financial Statements ..
11/17 RITE AID : Announces Senior Management Changes in Category Management
11/15 RITE AID : Overnight Work Continues At Mono Way And Greenley Intersection
11/15 RITE AID : Woman demands prescription drugs from Rite Aid in Easton, police say
11/14 RITE AID : Rob Mullins Named Senior Vice President of Store Operations, Western ..
11/14 RITE AID : Foundation Unveils KIDCHAMP Program
11/14 RITE AID : Foundation Unveils KIDCHAMPSM Program
More news
News from SeekingAlpha
11/22 DIVIDEND ARISTOCRATS IN FOCUS PART 4 : Walgreens Boots Alliance
11/21 Cowen analyst says Amazon should buy Rite Aid
11/18 RGA Q3 2017 Letter - Amazon's Share Of E-Commerce = PayPal's Opportunity
11/16 Tracking David Einhorn's Portfolio - Q3 2017 Update
11/15 RITE AID : Prefer The Bonds Over The Stock
Financials ($)
Sales 2018 29 486 M
EBIT 2018 177 M
Net income 2018 66,0 M
Debt 2018 3 934 M
Yield 2018 -
P/E ratio 2018 26,00
P/E ratio 2019 39,76
EV / Sales 2018 0,19x
EV / Sales 2019 0,20x
Capitalization 1 798 M
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 2,18 $
Spread / Average Target 29%
EPS Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kermit R. Crawford President & Chief Operating Officer
Bryan B. Everett Chief Operating Officer-Rite Aid Stores
Darren W. Karst Chief Financial & Administrative Officer, SEVP
Steve Rempel Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION-79.49%1 798
RAIA DROGASIL SA43.29%8 933
PALTAC CORP67.87%2 643
AIN HOLDINGS INC-8.91%2 239
SOGO MEDICAL CO LTD41.33%835
PETMED EXPRESS INC73.52%825